Intercept Pharmaceuticals Inc. News
Intercept Pharma Stock Falls as Goldman Cuts to Sell
Intercept Pharma shares traded lower after Goldman Sachs downgraded the stock to sell and lowered its price target to $10 from $17.
Intercept Pharmaceuticals to Reduce Its Workforce by 25%
Intercept Pharmaceuticals expects the job cuts to cost about $18 million.
Intercept Stock Off - FDA Declines to Clear Liver-Disease Drug
Intercept Pharmaceuticals shares fell after the FDA declined to clear its drug for a progressive liver disease.
Shares of Intercept Pharmaceuticals Rise Sharply on Drug Trial Results
Intercept Pharmaceuticals surges Tuesday after the release of positive test results for a new liver disease drug.
Novocure Shares Jump On Phase 3 Data - Biotech Movers
The St. Helier, Jersey-based firm said a Phase 3 study of Optune in tandem with temozolomide in newly diagnosed glioblastoma "demonstrated unprecedented five-year survival results."
GameStop Stock Surges On Plans For 4-For-1 Stock Split
GameStop will pay a three-share dividend to investors on July 21, with the stock trading on a split-adjusted basis the following day.
Samsung Forecasts Best Quarterly Profits In Four Years, Boosting US Chip Stocks
Chipmakers Intel and Nvidia got a boost Thursday after Samsung Electronic forecast its strongest quarterly profits in four years.
Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck & Co.
Merck is reportedly eying cancer drug specialists Seagen as it looks to replace revenue from its Keytruda blockbuster, which loses patent exclusivity in 2028.
Costco Raises Two Key Food-Court Prices (But Not Hot Dogs)
The Costco warehouse club has been hesitant to pass on price increases to customers, but two popular menu items in its food court now cost more.